Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04284930 · ClinicalTrials.gov registry record · Phase 4
Comparison of Local Anesthetic Infusion Pump Versus Depofoam Bupivacaine for Pain Management
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT04284930: Completed Phase 4 study, sponsored by The Cleveland Clinic.
NCT04284930 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 21 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04284930, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
Effective post surgical pain control in patients undergoing unilateral deep inferior epigastric perforator (DIEP) free flap reconstruction.
Primary Outcome
Post-op pain measured by total post-op Morphine equivalents
Interventions
- DRUG 0.25% Bupivacaine
- DRUG Depobupivacaine
- DRUG OnQ pump
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-11 |
| Phase | Phase 4 |
What the finished NCT04284930 record still lists
NCT04284930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which 0.25% Bupivacaine is the first listed.
NCT04284930 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04284930 about?
NCT04284930 is a clinical study titled "Comparison of Local Anesthetic Infusion Pump Versus Depofoam Bupivacaine for Pain Management". Effective post surgical pain control in patients undergoing unilateral deep inferior epigastric perforator (DIEP) free flap reconstruction.
What is the current status of trial NCT04284930?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2016-02. Estimated completion is 2017-11.
What interventions are being tested in trial NCT04284930?
The interventions under investigation include: 0.25% Bupivacaine (DRUG), Depobupivacaine (DRUG), OnQ pump (DRUG).
Who is sponsoring clinical trial NCT04284930?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04284930's enrollment target sits among peer trials
21 1742nd of 2000 higher than 248 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia